[1]
“The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Infliximab as Compared to Etanercept: Systematic Review and Metanalysis”, PPCR, vol. 9, no. 3, Nov. 2023, doi: 10.21801/ppcrj.2023.93.3.